{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:11:35Z","timestamp":1780485095054,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"am","delay-in-days":298,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microvascular Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.mvr.2024.104720","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T12:26:39Z","timestamp":1723119999000},"page":"104720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Dynamics of scFv-targeted VAP2 correlating with IL-16, MIF and IL-1Ra in ANCA-associated vasculitis"],"prefix":"10.1016","volume":"156","author":[{"given":"Junya","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kameoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyu","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Uno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fukuko","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mvr.2024.104720_bb0005","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.ekir.2017.09.008","article-title":"The European Vasculitis Society 2016 meeting report","volume":"2","author":"Bajema","year":"2017","journal-title":"Kidney Int Rep."},{"key":"10.1016\/j.mvr.2024.104720_bb0010","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0272-6386(03)00025-8","article-title":"Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study","volume":"41","author":"Booth","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.mvr.2024.104720_bb0015","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/art.41776","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.mvr.2024.104720_bb0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.actbio.2019.04.051","article-title":"Injectable biomaterials for delivery of interleukin-1 receptor antagonist: toward improving its therapeutic effect","volume":"93","author":"Clements","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mvr.2024.104720_bb0025","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1042\/BJ20121210","article-title":"Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl)","volume":"449","author":"Hadfield","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.mvr.2024.104720_bb0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/14397595.2018.1500437","article-title":"2017 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis","volume":"29","author":"Harigai","year":"2019","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.mvr.2024.104720_bb0035","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000744","article-title":"Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis","volume":"9","author":"H\u00e4yry","year":"2022","journal-title":"Lupus Sci Med."},{"key":"10.1016\/j.mvr.2024.104720_bb0040","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1172\/JCI67478","article-title":"Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex","volume":"123","author":"Huang","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mvr.2024.104720_bb0045","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nm.3459","article-title":"An abundant dysfunctional apolipoprotein A1 in human atheroma","volume":"20","author":"Huang","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.mvr.2024.104720_bb0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12969-022-00783-7","article-title":"Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease","volume":"20","author":"Ito","year":"2022","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.mvr.2024.104720_bb0055","doi-asserted-by":"crossref","first-page":"c35","DOI":"10.1159\/000088313","article-title":"Clinical efficacy of intravenous immunoglobulin for patients with MPO-ANCA-associated rapidly progressive glomerulonephritis","volume":"102","author":"Ito-Ihara","year":"2006","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.mvr.2024.104720_bb0060","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","article-title":"Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity","volume":"93","author":"Jayne","year":"2000","journal-title":"QJM"},{"key":"10.1016\/j.mvr.2024.104720_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.mvr.2024.104720_bb0070","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1681\/ASN.2021081112","article-title":"Targeting cathepsin C in PR3-ANCA vasculitis","volume":"33","author":"Jerke","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mvr.2024.104720_bb0075","first-page":"44","article-title":"Establishment of a library having 204 effective clones of recombinant single chain fragment of variable region (hScFv) of IgG for vasculitis treatment","volume":"4","author":"Kameoka","year":"2017","journal-title":"ADC Letter for Infectious Disease Control"},{"key":"10.1016\/j.mvr.2024.104720_bb0080","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2147\/DDDT.S188651","article-title":"Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis","volume":"13","author":"Kameoka","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.mvr.2024.104720_bb0085","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41584-019-0238-2","article-title":"The immunobiology of MIF: function, genetics and prospects for precision medicine","volume":"15","author":"Kang","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.mvr.2024.104720_bb0090","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nrneph.2013.71","article-title":"Vasculitis: epitope specificity responsible for MPO-ANCA pathogenicity","volume":"9","author":"Kelsey","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.mvr.2024.104720_bb0095","doi-asserted-by":"crossref","first-page":"20638","DOI":"10.1038\/s41598-021-98253-9","article-title":"Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach","volume":"11","author":"Kimura","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mvr.2024.104720_bb0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/cei\/uxad140","article-title":"Enhanced efficacy of the novel recombinant clone VasSF in a mouse model of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"216","author":"Koura","year":"2024","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.mvr.2024.104720_bb0105","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"Luqmani","year":"1994","journal-title":"QJM"},{"key":"10.1016\/j.mvr.2024.104720_bb0110","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.mvr.2024.104720_bb0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12929-017-0382-4","article-title":"Psoriasis-associated vascular disease: the role of HDL","volume":"24","author":"Paiva-Lopes","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.mvr.2024.104720_bb0120","first-page":"104","article-title":"Interleukin 12 and myeloperoxidase (MPO) in Vietnamese children with acute respiratory distress syndrome due to Avian influenza (H5N1) infection","volume":"62","author":"Phung","year":"2011","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.mvr.2024.104720_bb0125","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/cddiscovery.2015.56","article-title":"Secondary necrotic neutrophils release interleukin-16C and macrophage migration inhibitory factor from stores in the cytosol","volume":"1","author":"Roth","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mvr.2024.104720_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11926-023-01123-8","article-title":"Cardiovascular disease in anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"26","author":"Sayer","year":"2024","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.mvr.2024.104720_bb0135","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/ndt\/gft469","article-title":"A novel autoantibody against moesin in the serum of patients with MPO-ANCA-associated vasculitis","volume":"29","author":"Suzuki","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.mvr.2024.104720_bb0140","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13023-023-02782-7","article-title":"Subclinical microvascular changes in ANCA-vasculitides: the role of optical coherence tomography angiography and nailfold capillaroscopy in the detection of disease-related damage","volume":"18","author":"Triggianese","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.mvr.2024.104720_bb0145","first-page":"41","article-title":"Cytokine\/chemokine changes in plasma of patients with MPO-ANCA RPGN: before and after IVIg therapy","volume":"4","author":"Uno","year":"2017","journal-title":"ADC Letter for Infectious Disease Control."},{"key":"10.1016\/j.mvr.2024.104720_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155221","article-title":"Impaired HVJ-stimulated interferon producing capacity in MPO-ANCA-associated vasculitis with rapidly progressive glomerulonephritis lead to susceptibility to infection","volume":"136","author":"Uno","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.mvr.2024.104720_bb0155","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mvr.2024.104720_bb0160","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.mvr.2024.104720_bb0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13075-020-02172-5","article-title":"Serum interleukin-16 significantly correlates with the Vasculitis Damage Index in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"22","author":"Yoon","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.mvr.2024.104720_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.109914","article-title":"CD36 regulates macrophage and endothelial cell activation and multinucleate giant cell formation in anti neutrophil cytoplasm antibody vasculitis","volume":"260","author":"Zhang","year":"2024","journal-title":"Clin. Immunol."}],"container-title":["Microvascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286224000694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286224000694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:49:52Z","timestamp":1762213792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026286224000694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":34,"alternative-id":["S0026286224000694"],"URL":"https:\/\/doi.org\/10.1016\/j.mvr.2024.104720","relation":{},"ISSN":["0026-2862"],"issn-type":[{"value":"0026-2862","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamics of scFv-targeted VAP2 correlating with IL-16, MIF and IL-1Ra in ANCA-associated vasculitis","name":"articletitle","label":"Article Title"},{"value":"Microvascular Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mvr.2024.104720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104720"}}